Is it appropriate to prescribe diazepam for a post‑hemodialysis patient with restless‑leg syndrome?

Do Not Use Diazepam for Restless Leg Syndrome in Hemodialysis Patients

Diazepam should not be prescribed for restless leg syndrome (RLS) in post-hemodialysis patients, as the most recent 2025 American Academy of Sleep Medicine (AASM) guidelines explicitly recommend against the use of benzodiazepines, including clonazepam (a closely related agent), for RLS treatment. 1

Why Benzodiazepines Are Not Recommended

The 2025 AASM guidelines specifically state that clonazepam should not be used for RLS (conditional recommendation, very low certainty of evidence) 1. While diazepam is not explicitly mentioned in the guidelines, it belongs to the same benzodiazepine class and shares the same mechanism of action. The guideline's recommendation against clonazepam—which has historically been the most commonly used benzodiazepine for RLS—strongly suggests that diazepam is equally inappropriate.

Key Problems with Benzodiazepines in RLS:

• No proven efficacy: A 2017 Cochrane systematic review found zero studies meeting inclusion criteria demonstrating benzodiazepine effectiveness for RLS 2
• Symptomatic treatment only: Benzodiazepines may help with sleep initiation but do not address the underlying RLS pathophysiology
• Significant safety concerns in hemodialysis patients: Risk of oversedation, respiratory depression, falls, and cognitive impairment 3

What You Should Use Instead

First-Line Treatment for RLS in Hemodialysis Patients:

1. Gabapentin (conditional recommendation, very low certainty of evidence) 1

• Most appropriate first-line agent for ESRD patients
• Requires dose adjustment for renal function
• Meta-analysis shows gabapentinoids produce the largest symptom reductions 4

2. IV Iron Sucrose (conditional recommendation, moderate certainty of evidence) 1

• Use when ferritin < 200 ng/mL AND transferrin saturation < 20%
• Moderate-quality evidence specifically in ESRD population
• Address underlying iron deficiency common in dialysis patients

3. Vitamin C (conditional recommendation, low certainty of evidence) 1

• Adjunctive therapy option
• May improve iron metabolism

Second-Line Considerations:

Levodopa may be considered but AASM suggests against standard use due to augmentation risk (conditional recommendation, low certainty of evidence) 1. Use only if patients prioritize short-term symptom relief over long-term adverse effects.

Critical Safety Concerns with Diazepam

The FDA label for diazepam highlights multiple risks particularly relevant to hemodialysis patients 3:

• Respiratory depression risk: Especially dangerous when combined with opioids (which are sometimes used for refractory RLS)
• Abuse and dependence potential: Physical dependence develops with continued use
• Withdrawal seizures: Abrupt discontinuation can be life-threatening
• CNS depression: Increased fall risk in elderly dialysis patients
• Not indicated for RLS: FDA-approved only for anxiety, alcohol withdrawal, muscle spasm, and seizures 3

Common Pitfalls to Avoid

1. Don't prescribe benzodiazepines just because they help sleep: While RLS disrupts sleep, benzodiazepines don't treat the underlying sensorimotor symptoms and carry substantial risks

2. Don't assume diazepam is safe because it's been used during dialysis procedures: One small 1985 study showed diazepam could be used for procedural sedation 5, but this does not translate to chronic use for RLS

3. Don't confuse historical practice with current evidence: Older literature mentions benzodiazepines as treatment options 6, 7, but the 2025 AASM guidelines represent the most current, comprehensive evidence synthesis

Treatment Algorithm for RLS in Hemodialysis Patients

Step 1: Check iron parameters (ferritin and transferrin saturation)

• If ferritin < 200 ng/mL AND TSAT < 20%: Start IV iron sucrose 1

Step 2: Initiate gabapentin with renal dose adjustment

• Start low and titrate based on response and tolerability 1

Step 3: Add vitamin C as adjunctive therapy 1

Step 4: If inadequate response, consider dopaminergic agents (levodopa, rotigotine) with careful counseling about augmentation risk 1

Never: Use benzodiazepines including diazepam or clonazepam as standard treatment 1